Infections of the Female Pelvis

Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases

Volumn 1, Issue , 2014, Pages 1372.e1-1380.e2

  Soper, David E ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Antibiotic prophylaxis; Chorioamnionitis; Intra amniotic infection; Pelvic inflammatory disease; Polymicrobial infection; Postpartum endometritis; Septic abortion; Septic pelvic thrombophlebitis; Surgical site infection; Wound infection

Indexed keywords

EID: 84944546680     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4557-4801-3.00111-9     Document Type: Chapter

References (149)

1. Gibbs RS, Duff P Progress in pathogenesis and management of clinical intra-amniotic infection. Am J Obstet Gynecol 1991, 164:1317-1326.
2. Soper DE, Mayhall CG, Dalton HP Risk factors for intraamniotic infection: a prospective epidemiologic study. Am J Obstet Gynecol 1989, 161:562-568.
3. Gibbs RS, Blanco JD, St Clair PF, et al. Quantitative bac-teriology of amniotic fluid from women with clinical intraamniotic infection at term. J Infect Dis 1982, 145:1-8.
4. Kenyon S, Boulvain M, Neilson J Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev 2010, (8).
5. Newton ER, Piper J, Peairs W Bacterial vaginosis and intraamniotic infection. Am J Obstet Gynecol 1997, 176:672-677.
6. Lamont RF, Sobel J, Mazaki-Tovi S, et al. Listeriosis in human pregnancy: a systematic review. J Perinat Med 2011, 39:227-236.
7. Greenberg MB, Anderson BL, Schulkin J, et al. A first look at chorioamnionitis management practice variation among US obstetricians. Infect Dis Obstet Gynecol 2012, 2012:628362.
8. Gomez R, Romero R, Galasso M, et al. The value of amniotic fluid interleukin-6, white blood cell count, and Gram stain in the diagnosis of microbial invasion of the amniotic cavity in patients at term. Am J Reprod Immunol 1994, 32:200-210.
9. Edwards RK, Clark P, Locksmith GJ, et al. Performance characteristics of putative tests for subclinical chorioamnionitis. Infect Dis Obstet Gynecol 2001, 9:209-214.
10. Gibbs RS, Dinsmoor MJ, Newton ER, et al. A randomized trial of intrapartum versus immediate postpartum treatment of women with intraamniotic infection. Obstet Gynecol 1988, 72:823-828.
11. Hopkins L, Smaill F Antibiotic regimens for management of intraamniotic infection. Cochrane Database Syst Rev 2002, (3).
12. Black LP, Hinson L, Duff P Limited course of antibiotic treatment for chorioamnionitis. Obstet Gynecol 2012, 119:1102-1105.
13. Rouse DJ, Landon M, Leveno KJ, et al. The Maternal-Fetal Units Cesarean Registry: chorioamnionitis at term and its duration-relationship to outcomes. Am J Obstet Gynecol 2004, 191:211-216.
14. Seaward PG, Hannah ME, Myhr TL, et al. International multi-centre prelabor rupture of membranes study: evaluation of predictors of clinical chorioamnionitis and postpartum fever in patients with prelabor rupture of membranes at term. Am J Obstet Gynecol 1997, 177:1024-1029.
15. Watts DH, Krohn MA, Hillier SL, et al. Bacterial vaginosis as a risk factor for postcesarean endometritis. Obstet Gynecol 1990, 75:52-58.
16. Chang PL, Newton ER Predictors of antibiotic prophylactic failure in post-cesarean endometritis. Obstet Gynecol 1992, 80:117-122.
17. Tita AT, Rouse DJ, Blackwell SM, et al. Emerging concepts in antibiotic prophylaxis for cesarean delivery: a systematic review. Obstet Gynecol 2009, 113:675-682.
18. Constantine MM, Rahman M, Ghulmiyah L, et al. Timing of perioperative antibiotics for cesarean delivery: a metaanalysis. Am J Obstet Gynecol 2008, 199:301.e1-301.e6.
19. Gonik B, Shannon RL, Shawar R, et al. Why patients fail antibiotic prophylaxis at cesarean delivery: histologic evidence for incipient infection. Obstet Gynecol 1992, 79:179-184.
20. Watts DH, Eschenbach DA, Kenny GE Early postpartum endometritis: the role of bacteria, genital mycoplasmas, and Chlamydia trachomatis. Obstet Gynecol 1989, 73:52-60.
21. Eschenbach DA, Rosene K, Tompkins LS, et al. Endometrial cultures obtained by a triple-lumen method from afebrile and febrile postpartum women. J Infect Dis 1986, 153:1038-1045.
22. Watts DH, Hillier SL, Eschenbach DA Upper genital tract isolates at delivery as predictors of post-cesarean infection among women receiving antibiotic prophylaxis. Obstet Gynecol 1991, 77:287-292.
23. Roberts S, Maccato M, Faro S, et al. The microbiology of post-cesarean wound morbidity. Obstet Gynecol 1993, 81:383-386.
24. Hoyme UB, Kiviat N, Eschenbach DA The microbiology and treatment of late postpartum endometritis. Obstet Gynecol 1986, 68:226-232.
25. Van Beneden CA, Hicks LA, Riley LE, et al. Provider knowledge, attitudes, and practices regarding obstetric and postsurgical gynecologic infections due to group A Streptococcus and other infectious agents. Infect Dis Obstet Gynecol 2007, 2007:90189.
26. Martens MG, Faro S, Hammil HA, et al. Transcervical uterine cultures with a new endometrial suction curette: a comparison of three sampling methods in postpartum endometritis. Obstet Gynecol 1989, 74:273-276.
27. French LM, Smaill FM Antibiotic regimens for endometritis after delivery. Cochrane Database Syst Rev 2004, (4).
28. Dinsmoor MJ, Newton ER, Gibbs RS A randomized, double-blind, placebo-controlled trial of oral antibiotic therapy following intravenous antibiotic therapy for postpartum endometritis. Obstet Gynecol 1991, 77:60-62.
29. Soper DE, Brockwell NJ, Dalton HP The importance of wound infection in antibiotic failures in the therapy of postpartum endometritis. Surg Gynecol Obstet 1992, 174:265-269.
30. Aldridge KE, Broyles S, Master R. Clindamycin in contemporary ob-gyn: considerations of antibiotic resistance among beta-hemolytic streptococci and anaerobes (Abstract). Presented at the 30th Annual Scientific Meeting of the Infectious Disease Society for Obstetrics and Gynecology, Hyannis, MA, August 7-9, 2003.
31. Noronha S, Yue C, Sekosan M Puerperal group A beta-hemolytic streptococcal toxic shock-like syndrome. Obstet Gynecol 1996, 88:728.
32. Meis JF, Muytjens HC, van den Berg PP, et al. Analysis of an outbreak of puerperal fever due to group A streptococci by random amplified polymorphic DNA fingerprinting. Infect Dis Obstet Gynecol 1997, 5:232-236.
33. Centers for Disease Control and Prevention Nosocomial group A streptococcal infections associated with asymptomatic health care workers-Maryland and California, 1997. MMWR Morb Mortal Wkly Rep 1999, 48:163-166.
34. Dunn LJ, Van Voorhis LW Enigmatic fever and pelvic thrombophlebitis. N Engl J Med 1967, 276:265-268.
35. Brown CE, Stettler RW, Twickler D, et al. Puerperal septic pelvic thrombophlebitis: incidence and response to heparin therapy. Am J Obstet Gynecol 1999, 181:143-148.
36. Witlin AG, Mercer BM, Sibai BM Septic pelvic thrombophlebitis or refractory postpartum fever of undetermined etiology. J Matern Fetal Med 1996, 5:355-358.
37. Garcia J, Aboujaoude R, Apuzzio J, Alvarez JR Septic pelvic thrombophlebitis: diagnosis and management. Infect Dis Obstet Gynecol 2006, 2006:15614.
38. Duggal N, Mercado C, Daniels K, et al. Antibiotic prophylaxis for prevention of postpartum perineal wound complications: a randomized controlled trial. Obstet Gynecol 2008, 111:1268-1273.
39. Shy KK, Eschenbach DA Fatal perineal cellulitis from an episiotomy site. Obstet Gynecol 1979, 54:292-298.
40. Ramin SM, Ramus RM, Little BB, et al. Early repair of episiotomy dehiscence associated with infection. Am J Obstet Gynecol 1992, 167:1104-1107.
41. Soper DE Clostridial myonecrosis arising from an episiotomy. Obstet Gynecol 1986, 68:26S-28S.
42. McGregor JA, Soper DE, Lovell G, et al. Maternal deaths associated with Clostridium sordellii infection. Am J Obstet Gynecol 1989, 161:987-995.
43. Stubblefield PG, Grimes DA Septic abortion. N Engl J Med 1994, 331:310-314.
44. Sawaya GF, Grady D, Kerlikowske K, et al. Antibiotics at the time of induced abortion: the case for universal prophylaxis based on a meta-analysis. Obstet Gynecol 1996, 87:884-890.
45. Low N, Mueller M, Van Vliet HAAM, Kapp N Perioperative antibiotics to prevent infection after first-trimester abortion. Cochrane Database Syst Rev 2012, (3).
46. Fischer M, Bhatnagar J, Guarner J, et al. Fatal toxic shock syndrome associated with C. sordellii after medical abortion. N Engl J Med 2005, 353:2352-2360.
47. Cruise PJ Surgical wound infection. Infectious Diseases 1992, 758-764. Saunders, Philadelphia. M.J. Wonsiewicz (Ed.).
48. Krizek TJ, Robson MC Evolution of quantitative bacte-riology in wound management. Am J Surg 1975, 130:579-584.
49. James RC, MacLeod CJ Induction of staphylococcal infections in mice with small inocula introduced on sutures. Br J Exp Pathol 1957, 38:573-586.
50. Eschenbach DA, Davick PR, Williams BL, et al. Prevalence of hydrogen peroxide producing Lactobacillus species in normal women and women with bacterial vaginosis. J Clin Microbiol 1989, 27:251-256.
51. Ohm MJ, Galask RP The effect of antibiotic prophylaxis on patients undergoing vaginal operations. Am J Obstet Gynecol 1975, 123:597-604.
52. Ohm MJ, Galask RP The effect of antibiotic prophylaxis on patients undergoing total abdominal hysterectomy. Am J Obstet Gynecol 1976, 125:448-454.
53. Weinstein WM, Onderdonk AB, Bartlett JG, et al. Experimental intraabdominal abscesses in rats: development of an experimental model. Infect Immun 1974, 10:1250-1255.
54. Dicker RC, Greenspan JR, Strauss LT, et al. Complications of abdominal and vaginal hysterectomy among women of reproductive age in the United States. Am J Obstet Gynecol 1982, 144:841-848.
55. Shapiro M, Munoz A, Tager IB, et al. Risk factors for infection at the operative site after abdominal or vaginal hysterectomy. N Engl J Med 1982, 307:1661-1666.
56. Soper DE, Bump RC, Hurt WG Bacterial vaginosis and trichomoniasis vaginitis are risk factors for cuff cellulitis after abdominal hysterectomy. Am J Obstet Gynecol 1990, 163:1016-1023.
57. Larsson PG, Carlsson B Does pre- and postoperative metronidazole treatment lower vaginal cuff infection rate after abdominal hysterectomy among women with bacterial vaginosis?. Infect Dis Obstet Gynecol 2002, 10:133-140.
58. Hemsell DL Posthysterectomy infections. Infectious Diseases in Women 2001, 284-292. Saunders, Philadelphia. S. Faro, D.E. Soper (Eds.).
59. DeCenzo JA Cuff abscess after vaginal hysterectomy. Obstet Gynecol 1968, 31:871.
60. Larsen JW, Hager WD, Livengood CH, et al. Guidelines for the diagnosis, treatment and prevention of postoperative infections. Infect Dis Obstet Gynecol 2003, 11:65-70.
61. Ledger WJ, Campbell C, Wilson JR Postoperative adnexal infection. Obstet Gynecol 1968, 31:83-89.
62. Livengood CH, Addison WA Adnexal abscess as a delayed complication of vaginal hysterectomy. Am J Obstet Gynecol 1982, 143:596-597.
63. Ledger WJ, Moore DE, Lowensohn RI, et al. A fever index evaluation of chloramphenicol or clindamycin in patients with serious pelvic infections. Obstet Gynecol 1977, 50:523-530.
64. Harisinghani MG, Gervais DA, Maher MM, et al. Transgluteal approach for percutaneous drainage of deep pelvic abscesses. Radiology 2003, 228:701-705.
65. Ryan RS, McGrath FP, Haslam PJ, et al. Ultrasound-guided endocavitary drainage of pelvic abscesses: technique, results and complications. Clin Radiol 2003, 58:75-79.
66. Corsi PJ, Johnson SC, Gonik B, et al. Transvaginal ultrasound-guided aspiration of pelvic abscesses. Infect Dis Obstet Gynecol 1999, 7:216-221.
67. Lentz SS Osteitis pubis: a review. Obstet Gynecol Surv 1995, 50:310-315.
68. Kammerer-Doak DN, Cornella JL, Magrina JF, et al. Osteitis pubis after Marshall-Marchetti-Krantz urethropexy: a pubic osteomyelitis. Am J Obstet Gynecol 1998, 179:586-590.
69. Lupovitch A, Elie JC, Wysocki R Diagnosis of acute bacterial osteomyelitis of the pubis by means of fine needle aspiration. Acta Cytol 1989, 33:649-651.
70. Sexton DJ, Heskestad L, Lambeth WR, et al. Postoperative pubic osteomyelitis misdiagnosed as osteitis pubis: report of four cases and review. Clin Infect Dis 1993, 17:695-700.
71. Weidner AC, Cundiff GW, Harris RL, et al. Sacral osteomyelitis: an unusual complication of abdominal sacral colpopexy. Obstet Gynecol 1997, 90:689-691.
72. Eckert LO, Hawes SE, Wolner-Hanssen PK, et al. Endometritis: the clinical-pathologic syndrome. Am J Obstet Gynecol 2002, 186:690-695.
73. Patton DL, Moore DE, Spandoni LR, et al. Comparison of the fallopian tube's response to both overt and silent salpingitis. Obstet Gynecol 1989, 63:622-630.
74. Westrom L, Wolner-Hanssen P Pathogenesis of pelvic inflammatory disease. Genitourin Med 1993, 69:9-17.
75. Wiesenfeld HC, Hillier SL, Krohn MA, et al. Lower genital tract infection and endometritis: insight into subclinical pelvic inflammatory disease. Obstet Gynecol 2002, 100:456-463.
76. Sweet RL, Draper DL, Schachter J, et al. Microbiology and pathogenesis of acute salpingitis as determined by laparoscopy: what is the appropriate site to sample?. Am J Obstet Gynecol 1980, 138:985-989.
77. Soper DE, Brockwell NJ, Dalton HP, et al. Observations concerning the microbial etiology of acute salpingitis. Am J Obstet Gynecol 1994, 170:1008-1017.
78. Hillier SL, Kiviat NB, Hawes SE, et al. Role of bacterial vaginosis-associated microorganisms in endometritis. Am J Obstet Gynecol 1996, 175:435-441.
79. Paavonen J, Lehtinen M, Teisala K, et al. Haemophilus influenzae causes purulent salpingitis. Am J Obstet Gynecol 1985, 151:338-339.
80. Monif GR, Williams BT, Dase DF Group A streptococcus as a cause of endometritis/salpingitis/peritonitis in a nongravid female. Obstet Gynecol 1977, 50:509-510.
81. Washington AE, Aral SO, Wolner-Hanssen P, et al. Assessing the risk for pelvic inflammatory disease and its sequelae. JAMA 1991, 266:2581-2586.
82. Sweet RL Role of bacterial vaginosis in pelvic inflammatory disease. Clin Infect Dis 1995, 20(Suppl 2):S271-S275.
83. Ness RB, Keder LM, Soper DE, et al. Oral contraception and the recognition of endometritis. Am J Obstet Gynecol 1997, 176:580-585.
84. Sweet RL, Blankfort-Doyle M, Robbie MO, et al. The occurrence of chlamydial and gonococcal salpingitis during the menstrual cycle. JAMA 1986, 255:2062-2064.
85. Ness RB, Soper DE, Holley RL, et al. Douching and endometritis: results from the PID evaluation and clinical health (PEACH) study. Sex Transm Dis 2000, 28:240-245.
86. Grimes DA Intrauterine device and upper-genital-tract infection. Lancet 2000, 356:1013-1019.
87. Persson E Genital actinomycosis and Actinomyces israelii in the female genital tract. Adv Contracept 1987, 3:115-123.
88. Lippes J Pelvic actinomycosis: a review and preliminary look at prevalence. Am J Obstet Gynecol 1999, 180:265-269.
89. Krettek JE, Arkin SI, Chaisilwattana P, et al. Chlamydia trachomatis in patients who used oral contraceptives and had intermenstrual spotting. Obstet Gynecol 1993, 81:728-731.
90. Yudin MH, Hillier SL, Wiesenfield HC, et al. Vaginal polymorphonuclear leukocytes and bacterial vaginosis as markers for histologic endometritis among women without symptoms of pelvic inflammatory disease. Am J Obstet Gynecol 2003, 188:318-323.
91. Eschenbach DA, Wolner-Hanssen P, Hawes SE, et al. Acute pelvic inflammatory disease: associations of clinical and laboratory findings with laparoscopic findings. Obstet Gynecol 1997, 89:184-192.
92. Ness RB, Soper DE, Holley RL, et al. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial. Am J Obstet Gynecol 2002, 186:929-937.
93. Centers for Disease Control and Prevention Updated recommended treatment regimens for gonococcal infections and associated conditions-United States, April 2007. MMWR Morb Mortal Wkly Rep 2007, http://www.cdc.gov/std/treatment/2006/updated-regimens.htm.
94. Haggerty CL, Ness RB Newest approaches to treatment of pelvic inflammatory disease: a review of recent randomized trials. Clin Infect Dis 2007, 44:953-960.
95. Gilstrap LC, Herbert WN, Cunningham FG, et al. Gonorrhea screening in male consorts of women with pelvic infection. JAMA 1977, 238:965-966.
96. Reed SD, Landers DV, Sweet RL Antibiotic treatment of tuboovarian abscess: comparison of broad-spectrum beta-lactam agents versus clindamycin-containing regimens. Am J Obstet Gynecol 1991, 164:1556-1561.
97. McNeeley SG, Hendrix SG, Mazzoni MM, et al. Medically sound, cost-effective treatment of pelvic inflammatory disease and tuboovarian abscess. Am J Obstet Gynecol 1998, 178:1272-1278.
98. Weisenfeld HC, Sweet RL Progress in the management of tuboovarian abscesses. Clin Obstet Gynecol 1993, 36:433-444.
99. Westrom L, Joesoef R, Reynolds G, et al. Pelvic inflammatory disease and fertility: a cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis 1992, 19:185-192.
100. Scholes D, Stergachis A, Heidrich FE, et al. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996, 334:1362-1366.
101. Lamont RF, Sobel J, Mazaki-Tovi S, et al. Listeriosis in human pregnancy: a systematic review. J Perinat Med 2011, 39:227-236.
102. Greenberg MB, Anderson BL, Schulkin J, et al. A first look at chorioamnionitis management practice variation among US obstetricians. Infect Dis Obstet Gynecol 2012, 2012:628362.
103. Hopkins L, Smaill F Antibiotic regimens for management of intraamniotic infection. Cochrane Database Syst Rev 2002, (3).
104. Black LP, Hinson L, Duff P Limited course of antibiotic treatment for chorioamnionitis. Obstet Gynecol 2012, 119:1102-1105.
105. Seaward PG, Hannah ME, Myhr TL, et al. International multi-centre prelabor rupture of membranes study: evaluation of predictors of clinical chorioamnionitis and postpartum fever in patients with prelabor rupture of membranes at term. Am J Obstet Gynecol 1997, 177:1024-1029.
106. Chang PL, Newton ER Predictors of antibiotic prophylactic failure in post-cesarean endometritis. Obstet Gynecol 1992, 80:117-122.
107. Tita AT, Rouse DJ, Blackwell SM, et al. Emerging concepts in antibiotic prophylaxis for cesarean delivery: a systematic review. Obstet Gynecol 2009, 113:675-682.
108. Constantine MM, Rahman M, Ghulmiyah L, et al. Timing of perioperative antibiotics for cesarean delivery: a metaanalysis. Am J Obstet Gynecol 2008, 199:301.e1-301.e6.
109. Gonik B, Shannon RL, Shawar R, et al. Why patients fail antibiotic prophylaxis at cesarean delivery: histologic evidence for incipient infection. Obstet Gynecol 1992, 79:179-184.
110. Watts DH, Eschenbach DA, Kenny GE Early postpartum endometritis: the role of bacteria, genital mycoplasmas, and Chlamydia trachomatis. Obstet Gynecol 1989, 73:52-60.
111. Watts DH, Hillier SL, Eschenbach DA Upper genital tract isolates at delivery as predictors of post-cesarean infection among women receiving antibiotic prophylaxis. Obstet Gynecol 1991, 77:287-292.
112. Roberts S, Maccato M, Faro S, et al. The microbiology of post-cesarean wound morbidity. Obstet Gynecol 1993, 81:383-386.
113. French LM, Smaill FM Antibiotic regimens for endometritis after delivery. Cochrane Database Syst Rev 2004, (4).
114. Soper DE, Brockwell NJ, Dalton HP The importance of wound infection in antibiotic failures in the therapy of postpartum endometritis. Surg Gynecol Obstet 1992, 174:265-269.
115. Noronha S, Yue C, Sekosan M Puerperal group A beta-hemolytic streptococcal toxic shock-like syndrome. Obstet Gynecol 1996, 88:728.
116. Dunn LJ, Van Voorhis LW Enigmatic fever and pelvic thrombophlebitis. N Engl J Med 1967, 276:265-268.
117. Brown CE, Stettler RW, Twickler D, et al. Puerperal septic pelvic thrombophlebitis: incidence and response to heparin therapy. Am J Obstet Gynecol 1999, 181:143-148.
118. Witlin AG, Mercer BM, Sibai BM Septic pelvic thrombophlebitis or refractory postpartum fever of undetermined etiology. J Matern Fetal Med 1996, 5:355-358.
119. Garcia J, Aboujaoude R, Apuzzio J, Alvarez JR Septic pelvic thrombophlebitis: diagnosis and management. Infect Dis Obstet Gynecol 2006, 2006:15614.
120. Duggal N, Mercado C, Daniels K, et al. Antibiotic prophylaxis for prevention of postpartum perineal wound complications: a randomized controlled trial. Obstet Gynecol 2008, 111:1268-1273.
121. Shy KK, Eschenbach DA Fatal perineal cellulitis from an episiotomy site. Obstet Gynecol 1979, 54:292-298.
122. McGregor JA, Soper DE, Lovell G, et al. Maternal deaths associated with Clostridium sordellii infection. Am J Obstet Gynecol 1989, 161:987-995.
123. Stubblefield PG, Grimes DA Septic abortion. N Engl J Med 1994, 331:310-314.
124. Sawaya GF, Grady D, Kerlikowske K, et al. Antibiotics at the time of induced abortion: the case for universal prophylaxis based on a meta-analysis. Obstet Gynecol 1996, 87:884-890.
125. Low N, Mueller M, Van Vliet HAAM, Kapp N Peri-operative antibiotics to prevent infection after first-trimester abortion. Cochrane Database Syst Rev 2012, (3).
126. Fischer M, Bhatnagar J, Guarner J, et al. Fatal toxic shock syndrome associated with C. sordellii after medical abortion. N Engl J Med 2005, 353:2352-2360.
127. Weinstein WM, Onderdonk AB, Bartlett JG, et al. Experimental intraabdominal abscesses in rats: development of an experimental model. Infect Immun 1974, 10:1250-1255.
128. Shapiro M, Munoz A, Tager IB, et al. Risk factors for infection at the operative site after abdominal or vaginal hysterectomy. N Engl J Med 1982, 307:1661-1666.
129. Soper DE, Bump RC, Hurt WG Bacterial vaginosis and trichomoniasis vaginitis are risk factors for cuff cellulitis after abdominal hysterectomy. Am J Obstet Gynecol 1990, 163:1016-1023.
130. Hemsell DL Posthysterectomy infections. Infectious Diseases in Women 2001, 284-292. Saunders, Philadelphia. S. Faro, D.E. Soper (Eds.).
131. Larsen JW, Hager WD, Livengood CH, et al. Guidelines for the diagnosis, treatment and prevention of postoperative infections. Infect Dis Obstet Gynecol 2003, 11:65-70.
132. Ledger WJ, Campbell C, Wilson JR Postoperative adnexal infection. Obstet Gynecol 1968, 31:83-89.
133. Livengood CH, Addison WA Adnexal abscess as a delayed complication of vaginal hysterectomy. Am J Obstet Gynecol 1982, 143:596-597.
134. Lentz SS Osteitis pubis: a review. Obstet Gynecol Surv 1995, 50:310-315.
135. Eckert LO, Hawes SE, Wolner-Hanssen PK, et al. Endometritis: the clinical-pathologic syndrome. Am J Obstet Gynecol 2002, 186:690-695.
136. Westrom L, Wolner-Hanssen P Pathogenesis of pelvic inflammatory disease. Genitourin Med 1993, 69:9-17.
137. Soper DE, Brockwell NJ, Dalton HP, et al. Observations concerning the microbial etiology of acute salpingitis. Am J Obstet Gynecol 1994, 170:1008-1017.
138. Hillier SL, Kiviat NB, Hawes SE, et al. Role of bacterial vaginosis-associated microorganisms in endometritis. Am J Obstet Gynecol 1996, 175:435-441.
139. Sweet RL, Blankfort-Doyle M, Robbie MO, et al. The occurrence of chlamydial and gonococcal salpingitis during the menstrual cycle. JAMA 1986, 255:2062-2064.
140. Grimes DA Intrauterine device and upper-genital-tract infection. Lancet 2000, 356:1013-1019.
141. Lippes J Pelvic actinomycosis: a review and preliminary look at prevalence. Am J Obstet Gynecol 1999, 180:265-269.
142. Krettek JE, Arkin SI, Chaisilwattana P, et al. Chlamydia trachomatis in patients who used oral contraceptives and had intermenstrual spotting. Obstet Gynecol 1993, 81:728-731.
143. Yudin MH, Hillier SL, Wiesenfield HC, et al. Vaginal polymorphonuclear leukocytes and bacterial vaginosis as markers for histologic endometritis among women without symptoms of pelvic inflammatory disease. Am J Obstet Gynecol 2003, 188:318-323.
144. Eschenbach DA, Wolner-Hanssen P, Hawes SE, et al. Acute pelvic inflammatory disease: associations of clinical and laboratory findings with laparoscopic findings. Obstet Gynecol 1997, 89:184-192.
145. Ness RB, Soper DE, Holley RL, et al. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial. Am J Obstet Gynecol 2002, 186:929-937.
146. Haggerty CL, Ness RB Newest approaches to treatment of pelvic inflammatory disease: a review of recent randomized trials. Clin Infect Dis 2007, 44:953-960.
147. Reed SD, Landers DV, Sweet RL Antibiotic treatment of tuboovarian abscess: comparison of broad-spectrum beta-lactam agents versus clindamycin-containing regimens. Am J Obstet Gynecol 1991, 164:1556-1561.
148. Weisenfeld HC, Sweet RL Progress in the management of tuboovarian abscesses. Clin Obstet Gynecol 1993, 36:433-444.
149. Scholes D, Stergachis A, Heidrich FE, et al. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996, 334:1362-1366.